Martingale Asset Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72M | Buy |
140,601
+16,718
| +13% | +$205K | 0.04% | 333 |
|
|
2025
Q1 | $1.78M | Buy |
123,883
+19,186
| +18% | +$275K | 0.05% | 326 |
|
|
2024
Q4 | $1.67M | Buy |
104,697
+5,868
| +6% | +$93.4K | 0.04% | 346 |
|
|
2024
Q3 | $2.37M | Buy |
98,829
+39,366
| +66% | +$946K | 0.05% | 269 |
|
|
2024
Q2 | $1.18M | Sell |
59,463
-5,599
| -9% | -$112K | 0.03% | 414 |
|
|
2024
Q1 | $1.3M | Sell |
65,062
-27,622
| -30% | -$550K | 0.03% | 407 |
|
|
2023
Q4 | $2.08M | Buy |
92,684
+1,464
| +2% | +$32.8K | 0.04% | 274 |
|
|
2023
Q3 | $1.84M | Buy |
91,220
+5,215
| +6% | +$105K | 0.04% | 284 |
|
|
2023
Q2 | $2.2M | Sell |
86,005
-3,348
| -4% | -$85.6K | 0.04% | 257 |
|
|
2023
Q1 | $2.66M | Buy |
89,353
+5,138
| +6% | +$153K | 0.05% | 215 |
|
|
2022
Q4 | $2.28M | Buy |
84,215
+48,848
| +138% | +$1.32M | 0.04% | 238 |
|
|
2022
Q3 | $771K | Buy |
35,367
+702
| +2% | +$15.3K | 0.02% | 509 |
|
|
2022
Q2 | $948K | Buy |
34,665
+1,405
| +4% | +$38.4K | 0.02% | 481 |
|
|
2022
Q1 | $1.12M | Sell |
33,260
-7,987
| -19% | -$268K | 0.02% | 452 |
|
|
2021
Q4 | $1.43M | Sell |
41,247
-18,450
| -31% | -$640K | 0.02% | 395 |
|
|
2021
Q3 | $1.86M | Buy |
59,697
+46,672
| +358% | +$1.46M | 0.02% | 330 |
|
|
2021
Q2 | $474K | Buy |
13,025
+3
| +0% | +$109 | 0.01% | 603 |
|
|
2021
Q1 | $570K | Buy |
+13,022
| New | +$570K | 0.01% | 576 |
|
|
2018
Q3 | – | Sell |
-14,305
| Closed | -$819K | – | 952 |
|
|
2018
Q2 | $819K | Sell |
14,305
-48,308
| -77% | -$2.77M | 0.01% | 778 |
|
|
2018
Q1 | $2.89M | Sell |
62,613
-38,146
| -38% | -$1.76M | 0.04% | 435 |
|
|
2017
Q4 | $4.65M | Sell |
100,759
-91
| -0.1% | -$4.2K | 0.06% | 315 |
|
|
2017
Q3 | $4.54M | Buy |
100,850
+2,211
| +2% | +$99.6K | 0.06% | 339 |
|
|
2017
Q2 | $3.88M | Buy |
98,639
+27,304
| +38% | +$1.07M | 0.05% | 355 |
|
|
2017
Q1 | $2.72M | Buy |
71,335
+600
| +0.8% | +$22.9K | 0.04% | 455 |
|
|
2016
Q4 | $2.62M | Buy |
70,735
+5,397
| +8% | +$200K | 0.04% | 476 |
|
|
2016
Q3 | $2.27M | Buy |
65,338
+35,615
| +120% | +$1.23M | 0.03% | 477 |
|
|
2016
Q2 | $967K | Buy |
+29,723
| New | +$967K | 0.02% | 515 |
|